Published in Drug Law Weekly, January 5th, 2010
Dr. Paul Harris, Vice President, Research and Development stated, "The continuation for the competitive claims significantly expands our U.S. intellectual property to allow coverage of assays for small molecules. This opens up whole new major markets in the areas of Therapeutic Drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2010-01-05)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.